| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 4, 161-168, Copyright © 1990 by The Federation of American Societies for Experimental Biology
REVIEWS |
NB Javitt
Division of Hepatic Diseases, New York University Medical Center, New York 10016.
Hep G2, a liver cell line derived from a human hepatoblastoma that is free of known hepatotropic viral agents, has been found to express a wide variety of liver-specific metabolic functions. Among these functions are those related to cholesterol and triglyceride metabolism. Confluent Hep G2 monolayers express normal low-density lipoprotein (LDL) receptors and continue to internalize and metabolize chylomicrons, very low-density lipoproteins (VLDL), LDL, and high- density lipoproteins. In lipoprotein-free medium, apolipoproteins A-I, A-II, B, C, and E accumulate in the medium together with cholesterol, cholesteryl ester, triglyceride, and all the primary bile acids. The regulation of their synthesis and secretion is not fully known and their interrelationships have not been established. Because Hep G2 cells express these and other components of cholesterol and triglyceride metabolism, they are a microcosm for studying the central role of the liver.
This article has been cited by other articles:
|
|
 |
|
  V. C. Cogger, I. M. Arias, A. Warren, A. C. McMahon, D. L. Kiss, V. M. Avery, and D. G. Le Couteur The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G137 - G145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aravindhan, C. L. Webb, M. Jaye, A. Ghosh, R. N. Willette, N. J. DiNardo, and B. M. Jucker Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study J. Lipid Res., June 1, 2006; 47(6): 1250 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W.H. Woo, Y. L. Siow, and K. O Homocysteine Activates cAMP-response Element Binding Protein in HepG2 Through cAMP/PKA Signaling Pathway Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1043 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Jackson, V. Maitin, D. S. Leake, P. Yaqoob, and C. M. Williams Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells J. Lipid Res., February 1, 2006; 47(2): 393 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mauzeroll, A. J. Bard, O. Owhadian, and T. J. Monks Menadione metabolism to thiodione in hepatoblastoma by scanning electrochemical microscopy PNAS, December 21, 2004; 101(51): 17582 - 17587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. S. Baker, S. D. Cramer, M. Kennedy, D. G. Assimos, and R. P. Holmes Glycolate and glyoxylate metabolism in HepG2 cells Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1359 - C1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kudo, E. Nakayama, S. Suzuki, M. Akiyama, and S. Shibata Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E644 - E651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Casaschi, G. K. Maiyoh, B. K. Rubio, R. W. Li, K. Adeli, and A. G. Theriault The Chalcone Xanthohumol Inhibits Triglyceride and Apolipoprotein B Secretion in HepG2 Cells J. Nutr., June 1, 2004; 134(6): 1340 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. She, S. Narindrasorasak, S. Yang, N. Spitale, E. A. Roberts, and B. Sarkar Identification of Metal-binding Proteins in Human Hepatoma Lines by Immobilized Metal Affinity Chromatography and Mass Spectrometry Mol. Cell. Proteomics, December 1, 2003; 2(12): 1306 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-S. Au, H.-f. Kung, and M. C. Lin Regulation of Microsomal Triglyceride Transfer Protein Gene by Insulin in HepG2 Cells: Roles of MAPKerk and MAPKp38 Diabetes, May 1, 2003; 52(5): 1073 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-L. Tseng, Y.-P. Shih, Y.-C. Huang, C.-K. Wang, P.-H. Chen, J.-G. Chang, K.-T. Yeh, Y.-M. A. Chen, and K. H. Buetow Genotypic and Phenotypic Characterization of a Putative Tumor Susceptibility Gene, GNMT, in Liver Cancer Cancer Res., February 1, 2003; 63(3): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Singh, O. A. Batuman, H. O. Akman, M. H. Kedees, V. Vakil, and M. M. Hussain Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor beta J. Biol. Chem., October 11, 2002; 277(42): 39515 - 39524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Munoz, M. Merlos, D. Zambon, C. Rodriguez, J. Sabate, E. Ros, and J. C. Laguna Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells J. Lipid Res., December 1, 2001; 42(12): 2069 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cantz, A. T. Nies, M. Brom, A. F. Hofmann, and D. Keppler MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G522 - G531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Goll, C Viollon-Abadie, L Nicod, and L Richert Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines Human and Experimental Toxicology, March 1, 2000; 19(3): 193 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 J C Goin, E S Borda, S Auger, R Storino, and L Sterin-Borda Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia Heart, September 1, 1999; 82(3): 273 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, M. T. Nakamura, H. P. Cho, and S. D. Clarke Sterol Regulatory Element Binding Protein-1 Expression Is Suppressed by Dietary Polyunsaturated Fatty Acids. A MECHANISM FOR THE COORDINATE SUPPRESSION OF LIPOGENIC GENES BY POLYUNSATURATED FATS J. Biol. Chem., August 13, 1999; 274(33): 23577 - 23583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Banfi, L. Mussoni, P. Rise, M. G. Cattaneo, L. Vicentini, F. Battaini, C. Galli, and E. Tremoli Very Low Density Lipoprotein–Mediated Signal Transduction and Plasminogen Activator Inhibitor Type 1 in Cultured HepG2 Cells Circ. Res., July 23, 1999; 85(2): 208 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Theriault, Q. Wang, A. Gapor, and K. Adeli Effects of {gamma}-Tocotrienol on ApoB Synthesis, Degradation, and Secretion in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 704 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Wilson, M. Z. Vasa, and R. G. Deeley Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region J. Lipid Res., May 1, 1998; 39(5): 1025 - 1032. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Rustan, B. Halvorsen, A. C. Huggett, T. Ranheim, and C. A. Drevon Effect of Coffee Lipids (Cafestol and Kahweol) on Regulation of Cholesterol Metabolism in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2140 - 2149. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Hayashi, M. Gohda, S. Matzno, Y. Kubo, H. Kido, T. Yamauchi, and N. Nakamura Possible Mechanism of Action of AE0047, a Calcium Antagonist, on Triglyceride Metabolism J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 882 - 890. [Abstract] [Full Text]
|
|
|
|
|
|
D. Wu and A. I. Cederbaum Ethanol Cytotoxicity to a Transfected HepG2 Cell Line Expressing Human Cytochrome P4502E1 J. Biol. Chem., September 27, 1996; 271(39): 23914 - 23919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Berkhout, H. M. Simon, D. D. Patel, C. Bentzen, E. Niesor, B. Jackson, and K. E. Suckling The Novel Cholesterol-lowering Drug SR-12813 Inhibits Cholesterol Synthesis via an Increased Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase J. Biol. Chem., June 14, 1996; 271(24): 14376 - 14382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Y. Chang, J. Chen, M. A. Thomas, D. Cheng, V. A. D. Priore, R. S. Newton, M. E. Pape, and T.-Y. Chang Regulation and Immunolocalization of Acyl-Coenzyme A:Cholesterol Acyltransferase in Mammalian Cells as Studied with Specific Antibodies J. Biol. Chem., December 8, 1995; 270(49): 29532 - 29540. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
